From confidence to capital: Positioning biotech for the next growth cyclebiopharmadive·Jul 27 at 10:38 AMLABU-8.48%LABD+8.30%
China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New HighAASTOCKS News·Jul 20 at 01:00 AM510660+0.86%159992+1.57%
Chinese biotech overtakes AI as emerging-market growth tradeBusinesstimes News·Jul 26 at 10:14 PM300765+5.61%AZN-0.75%
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20 at 01:00 AM513060+0.38%159859+1.32%
China's Outbound Licensing of Innovative Drugs in First Half Nears Last Year's TotalYicai·Jul 13 at 02:28 AM159859+1.32%513700+0.35%
On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global CollaborationsUnusual Whales·Jul 8 at 11:02 AMTMO-0.11%ARKG-1.69%
China’s biotech boom: RAS-targeted drugs challenge US dominanceSCMP·Jul 8 at 03:05 AM01276-0.52%600276-1.04%
SH Comp Gains 3 Pts at Half-Day; HUA HONG GRACE Surges Over 11%, Innovative Drug Concept Stocks RallyAASTOCKS News·Jul 5 at 11:05 PM399001+2.21%06969-2.23%
Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™Unusual Whales·Jul 3 at 09:32 AMARKG-1.69%159102+0.40%
China’s biotech boom: record 5,215 clinical drug trials reported in 2025SCMP·Jun 23 at 07:02 PM159615+0.59%159992+1.57%
Postbiotic Supplements Market Demand Reach USD 2.0 Billion by 2036 Amid Rising Demand for Gut Health and Microbiome-Based Wellness SolutionsUnusual Whales·Jun 22 at 11:15 AMFBT-2.60%LABD+8.30%
AI hype is 'blarney', semi stock prices will normalize: Bank Julius BaerMSN·Jun 25 at 09:15 PM513120+0.70%159837+1.04%
Bigger, fewer, tougher: the new era of China-US biotech partnershipsSCMP·Jun 20 at 11:03 PM600276-1.04%BMY+0.81%
10:01 ETPD-L1 Biomarker Testing Market to Reach USD 1,830.7 Million by 2036 as Precision Oncology and Immunotherapy Adoption Accelerate Global Demandprnewswire·Jun 16 at 09:02 AMLABD+8.30%159892+0.42%
